SCHEDULE 13G

Company

HALOZYME THERAPEUTICS, INC.

Filed

April 18, 2005

Accession Number

0000936392-05-000095

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →